A method and systems for determining an early warning score for a health status of a patient are provided. An example method includes acquiring, during a predetermined time period via sensors integrated into a wearable device worn on a wrist of the patient, initial values of medical parameters of patient. The medical parameters include a respiratory rate, oxygen saturation, temperature, blood pressure, and pulse rate, and level of consciousness. The method includes determining, based on the initial values, normal values of the medical parameters. The method includes acquiring, via the sensors and at a pre-determined frequency, further values of the medical parameters. The method includes determining, based on deviations of the further values from the normal values, individual scores for the medical parameters. The method includes calculating, based on the individual scores, a general score. The method includes determining, based on the general score, the health status of the patient.

A pressure relief apparatus with brain entrainment includes a resonant wave generating module and a bio-signal measuring unit. The resonant wave generating module includes multiple resonant devices, divided into multiple regions. Each of the resonant regions can respectively generate a resonant wave being changeable or turned off. The bio-signal measuring unit at least measures an energy of autonomic sympathetic nerve system LH and an energy of autonomic parasympathetic nerve system HF. According to a current one of a set of present conditions, a set of feedback control signals is output to the resonant wave generating module to modulate the resonant devices.

A method of targeting fibrosis or autonomic nerve tissue for ablation in a subject is provided. The method includes performing at least one EGM analysis of a plurality of recorded atrial EGMs for a tissue in a region suspected of having fibrosis or autonomic nerve tissue. With regard to targeting fibrosis for ablation, the method includes determining one or more correlations of at least one AF EGM characteristic to a region having fibrosis from the plurality of recorded atrial EGMs for the tissue and determining whether the tissue contains dense fibrosis that would preclude effective ablation of the analysis region of the tissue. With regard to targeting autonomic nerve for ablation, the method includes determining whether one or more significant changes in EGM characteristics with autonomic blockade exist that would indicate the need to perform ablation of the analysis region of the tissue.

An intravascular catheter for nerve activity ablation and/or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes near the distal ends of the needles allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered from the needles in or near the adventitia to ablate nerves outside of the media while sparing nerves within the media.

A method involves implantably detecting changes in posture of a patient's body. Baroreflex responses to the posture changes are determined. An autonomic tone of the patient is determined based on the baroreflex responses. Based on the autonomic tone, various patient susceptibilities to disease may be determined, including susceptibilities to heart disease, arrhythmia, and/or sudden cardiac death.

Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed.

A biosignal measuring method and apparatus are provided. The biosignal measuring method includes verifying whether a measured biosignal is in a range, and controlling an operation of the biosignal measuring apparatus when the measured biosignal deviates from the range based on a result of the verifying.

Disclosed is a system for monitoring physiological parameters during a medical interventional procedure involving high intensity/energy radiofrequency electrical currents/voltages applied through a body of a subject, the system including an electrode-based sensor, configured to close an electrical conduction path passing through a body of a subject, and one or more non-electrode-based sensors, a plurality of electrical lines, a monitor, and a filter array including EMI filters mounted at specific locations and characterized by a frequency response curve having a magnitude of an attenuation in a first frequency range (typical of operating frequencies of high intensity/energy radiofrequency medical interventional equipment), which is greater than a magnitude of an attenuation in a second frequency range (typical of the sampling frequencies of the electrode-based sensor and the one or more non-electrode-based sensors), the system being thereby configured for suppressing noise induced by the medical interventional equipment.

An apparatus for performing an activity based on a sympathetic nervous system (SNS) response to a stimulus includes an electrode configured to contact a person undergoing the stimulus. The apparatus also includes a processing unit having an algorithm programmed by machine-learning and configured to: (i) receive at least one of electrocardiogram (ECG) signals or electrodermal activity (EDA) signals from the electrode; (ii) analyze at least one of skin sympathetic nerve activity (SKNA) signals derived from the ECG signals or the EDA signals to measure the SNS response and provide an SNS response measurement; and (iii) transmit an SNS response measurement signal conveying the SNS response measurement to initiate the activity. The apparatus also includes an activity device configured to perform the activity in response to the SNS response measurement signal.

Apparatus is provided that includes left-nostril, right-nostril, and oral pressure sensors and oral pressure probes. A memory is configured to store left-nostril, right-nostril, and oral pressures sensed by the respective sensors, over a total period of at least 12 hours. A processor is configured to convert the left-nostril, right-nostril, and oral pressures stored in the memory to left-nostril, right-nostril, and oral pressure airflows, respectively, and calculate a series of orally-weighted laterality-indices over a respective series of sub-periods of the total period. Each of the orally-weighted laterality-indices of each of the sub-periods is indicative of a laterality index over the sub-period weighted by a normalized oral airflow over the sub-period, such that the greater the normalized oral airflow, the smaller the orally-weighted laterality-index. Each of the orally-weighted laterality-indices of each of the sub-periods reflects relative airflow through the left and the right nostrils over the sub-period. Other embodiments are also described.